Arama Sonuçları - Garrett M. Frampton
- Gösterilen 1 - 20 sonuçlar arası kayıtlar. 111
- Sonraki Sayfaya Git
-
1
Successful Treatment of HIV-Associated Kaposi Sarcoma with Immune Checkpoint Blockade Yazar: Natalie Galanina, Aaron M. Goodman, Philip R Cohen, Garrett M. Frampton, Razelle Kurzrock
Baskı/Yayın Bilgisi 2018Artigo -
2
Microsatellite-Stable Tumors with High Mutational Burden Benefit from Immunotherapy Yazar: Aaron M. Goodman, Ethan S. Sokol, Garrett M. Frampton, Scott M. Lippman, Razelle Kurzrock
Baskı/Yayın Bilgisi 2019Artigo -
3
-
4
<i>GNAS, GNAQ,</i>and<i>GNA11</i>alterations in patients with diverse cancers Yazar: Austin J. Parish, Vi Nguyen, Aaron M. Goodman, Karthikeyan Murugesan, Garrett M. Frampton, Razelle Kurzrock
Baskı/Yayın Bilgisi 2018Artigo -
5
Previously unidentified changes in renal cell carcinoma gene expression identified by parametric analysis of microarray data Yazar: Marc E. Lenburg, Louis S. Liou, Norman P. Gerry, Garrett M. Frampton, Herbert T. Cohen, Michael F. Christman
Baskı/Yayın Bilgisi 2003Artigo -
6
MET 14 Deletion in Sarcomatoid Non-Small-Cell Lung Cancer Detected by Next-Generation Sequencing and Successfully Treated with a MET Inhibitor Yazar: Carrie B. Lee, Dimitry Usenko, Garrett M. Frampton, Caitlin McMahon, Siraj M. Ali, Jared Weiss
Baskı/Yayın Bilgisi 2015Artigo -
7
-
8
Chromatin Structure and Gene Expression Programs of Human Embryonic and Induced Pluripotent Stem Cells Yazar: Matthew G. Guenther, Garrett M. Frampton, Frank Soldner, Dirk Hockemeyer, Maya Mitalipova, Rudolf Jaenisch, Richard A. Young
Baskı/Yayın Bilgisi 2010Artigo -
9
A clinico-genomic analysis of soft tissue sarcoma patients reveals CDKN2A deletion as a biomarker for poor prognosis Yazar: Nam Q. Bui, Joanna Przybył, Sally E. Trabucco, Garrett M. Frampton, Trevor Hastie, Matt van de Rijn, Kristen N. Ganjoo
Baskı/Yayın Bilgisi 2019Artigo -
10
Comprehensive genomic profiling identifies novel NTRK fusions in neuroendocrine tumors Yazar: Darren Sigal, Munveer S. Bhangoo, Jonathan A. Hermel, Dean C. Pavlick, Garrett M. Frampton, Vincent A. Miller, Jeffrey S. Ross, Siraj M. Ali
Baskı/Yayın Bilgisi 2018Artigo -
11
PARP Inhibitor Insensitivity to <i>BRCA1/2</i> Monoallelic Mutations in Microsatellite Instability-High Cancers Yazar: Ethan S. Sokol, Dexter X. Jin, Alexander D. Fine, Sally E. Trabucco, Sophia L. Maund, Garrett M. Frampton, Luciana Molinero, Emmanuel S. Antonarakis
Baskı/Yayın Bilgisi 2022Artigo -
12
Enhancer decommissioning by LSD1 during embryonic stem cell differentiation Yazar: Warren A. Whyte, Steve Bilodeau, David A. Orlando, Heather A. Hoke, Garrett M. Frampton, C. T. Foster, Shaun M. Cowley, Richard A. Young
Baskı/Yayın Bilgisi 2012Artigo -
13
APOBEC-related mutagenesis and neo-peptide hydrophobicity: implications for response to immunotherapy Yazar: Amélie Boichard, Timothy V. Pham, Huwate Yeerna, Aaron M. Goodman, Pablo Tamayo, Scott M. Lippman, Garrett M. Frampton, Igor F. Tsigelny, Razelle Kurzrock
Baskı/Yayın Bilgisi 2018Artigo -
14
The genomic landscape of metastatic breast cancer: Insights from 11,000 tumors Yazar: Jacob Rinaldi, Ethan S. Sokol, Ryan J. Hartmaier, Sally E. Trabucco, Garrett M. Frampton, Michael E. Goldberg, Lee A. Albacker, Anneleen Daemen, Gerard Manning
Baskı/Yayın Bilgisi 2020Artigo -
15
Ronin/Hcf-1 binds to a hyperconserved enhancer element and regulates genes involved in the growth of embryonic stem cells Yazar: Marion Déjosez, Stuart S. Levine, Garrett M. Frampton, Warren A. Whyte, Sabrina A. Stratton, Michelle Barton, Preethi H. Gunaratne, Richard A. Young, Thomas P. Zwaka
Baskı/Yayın Bilgisi 2010Artigo -
16
Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers Yazar: Aaron M. Goodman, Shumei Kato, Lyudmila Bazhenova, Sandip Pravin Patel, Garrett M. Frampton, Vincent A. Miller, Philip J. Stephens, Gregory A. Daniels, Razelle Kurzrock
Baskı/Yayın Bilgisi 2017Artigo -
17
Genomic landscape of advanced basal cell carcinoma: Implications for precision treatment with targeted and immune therapies Yazar: Aaron M. Goodman, Shumei Kato, Philip R. Cohen, Amélie Boichard, Garrett M. Frampton, Vincent A. Miller, Philip J. Stephens, Gregory A. Daniels, Razelle Kurzrock
Baskı/Yayın Bilgisi 2017Artigo -
18
Metastatic basal cell carcinoma with amplification of PD-L1: exceptional response to anti-PD1 therapy Yazar: Sadakatsu Ikeda, Aaron M. Goodman, Philip R. Cohen, Taylor J. Jensen, Christopher K. Ellison, Garrett M. Frampton, Vincent A. Miller, Sandip Pravin Patel, Razelle Kurzrock
Baskı/Yayın Bilgisi 2016Artigo -
19
Foxp3 occupancy and regulation of key target genes during T-cell stimulation Yazar: Alexander Marson, Karsten Kretschmer, Garrett M. Frampton, Elizabeth S Jacobsen, Julia K. Polansky, Kenzie D. MacIsaac, Stuart S. Levine, Ernest Fraenkel, Harald von Boehmer, Richard A. Young
Baskı/Yayın Bilgisi 2007Artigo -
20
Aberrant chromatin at genes encoding stem cell regulators in human mixed-lineage leukemia Yazar: Matthew G. Guenther, Lee N. Lawton, Tatiana Rozovskaia, Garrett M. Frampton, Stuart S. Levine, Thomas L. Volkert, Carlo M. Croce, Tatsuya Nakamura, Eli Canaani, Richard A. Young
Baskı/Yayın Bilgisi 2008Artigo
Arama Araçları:
İlgili Konular
Biology
Genetics
Medicine
Gene
Cancer
Cancer research
Internal medicine
Oncology
Mutation
Colorectal cancer
KRAS
Lung cancer
Pathology
Immunotherapy
Allele
Computational biology
Microsatellite
Microsatellite instability
Adenocarcinoma
Breast cancer
Genome
Cell biology
Exon
Gene expression
Bioinformatics
CDKN2A
Immunology
Copy-number variation
Immune checkpoint
Receptor